Healthy Volunteer Study Clinical Trial
Official title:
Efficacy of Intrathecal Oxytocin in Human Volunteers
The purpose of this study is to determine the effect of intrathecal oxytocin on areas and intensity of hyperalgesia and allodynia induced by topical capsaicin.
Purpose: There is a strong experimental basis to support the study of oxytocin by the spinal route for analgesia in humans. Oxytocin containing cells in the dorsal parvocellular division of the paraventricular nucleus (PVN) project to the spinal cord (1). Noxious stimulation activates these cells via the A1 noradrenergic relay in the pons (2) and produces analgesia by spinal release of oxytocin, since intrathecal injection of an oxytocin receptor antagonist worsens pain behaviors from peripheral inflammation (3). Direct electrical stimulation of the PVN reduces dorsal horn neuronal responses to noxious stimulation, and this is blocked by administration of sequestering antibody for oxytocin (4). Similarly, direct electrical stimulation of the PVN reduces behavioral sensitivity in a model of chronic neuropathic pain, and this effect is blocked by an oxytocin receptor antagonist (5). Intrathecal injection of oxytocin in normal rats reduces dorsal horn neuronal responses to noxious stimuli (6) as well as behavioral responses to noxious thermal (3), mechanical (3), and chemical (7) stimuli. Finally, intrathecal injection of oxytocin in rat models of chronic pain also reduces dorsal horn neuronal responses to sensory stimulation (6) as well as behavioral responses to thermal (5) and mechanical (7) stimuli. Rationale: We anticipate that oxytocin will be effective after spinal injection in humans against chemical induced hypersensitivity states. Objectives: Determine the effect of intrathecal oxytocin on areas and intensity of hyperalgesia and allodynia induced by topical capsaicin. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03270878 -
Glasdegib Absolute Bioavailability Study
|
Phase 1 | |
| Completed |
NCT03777488 -
Pharmacokinetics of Tranexamic Acid After Oral, Intramuscular or Intravenous Administration: a Prospective, Randomised, Cross-over Trial in Healthy Volunteers.
|
Phase 1 | |
| Completed |
NCT03086278 -
A Study of AST-008 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04711187 -
Study of AT-527 in Healthy Subjects (R07496998)
|
Phase 1 | |
| Completed |
NCT06141889 -
Pharmacokinetics Study of Azelaprag (BGE-105) in Older Adult Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05154123 -
Drug-drug Interaction Study of Rosuvastatin and AT-527 (R07496998)
|
Phase 1 | |
| Completed |
NCT05179421 -
Dose Ranging Study of Intravenous Oxytocin for Analgesia to Heat Pain
|
Phase 2 | |
| Completed |
NCT03945344 -
Effect of Charcoal on Gastrointestinal Absorption of Tiotropium
|
Phase 1 | |
| Recruiting |
NCT05881993 -
Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects
|
Early Phase 1 | |
| Completed |
NCT04242953 -
Study to Determine Safety, Tolerability and Pharmacokinetics, of SCO-120 in Healthy Male and Post-menopausal Female Subjects
|
Phase 1 | |
| Completed |
NCT02393950 -
Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00866385 -
AZD8566 Food Effect/Microtracer Study
|
Phase 1 | |
| Completed |
NCT04784000 -
Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527
|
Phase 1 | |
| Completed |
NCT01609218 -
A Study of LY2140023 in Healthy Participants
|
Phase 1 | |
| Completed |
NCT02503085 -
Ibuprofen Suspension Bioequivalence Study
|
Phase 1 | |
| Completed |
NCT05004415 -
Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)
|
Phase 1 | |
| Completed |
NCT02256423 -
A Study Comparing Three Formulations of Ibuprofen in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01425450 -
Safety Study of Four Doses of the Study Drug, HF1020 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05731843 -
Drug-drug Interaction Study of Ruzasvir and Bemnifosbuvir
|
Phase 1 | |
| Completed |
NCT03031535 -
Study of Intranasal Octreotide (DP1038) in Healthy Adult Volunteers
|
Phase 1 |